PFE - Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon Potentially Worth £2B | Benzinga
Pfizer Inc (NYSE:PFE) plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc (NYSE:HLN)
This move follows Pfizer’s earlier announcement that it will gradually divest its ownership in Haleon.
The offer price per share is set to be disclosed around March 19, after a book-building process, as stated by Haleon.
Pfizer intends to sell around 630 million shares, valued at about £2 billion based on Haleon’s closing price on Friday.
Haleon, recognized for brands like Sensodyne and Advil, emerged from a merger between Pfizer’s and GSK Plc’s (NYSE:GSK) consumer healthcare divisions in 2019, with Pfizer holding ...